
Paw Therapeutics applies AI to accelerate drug discovery and development in biotechnology. The company uses AI-driven Target Discovery Models and an Antibody Drug Library to identify candidates. It also offers an AI-powered Antibody Drug Optimisation Platform and a GMP-grade Pilot/Production Platform for antibody drugs. These platforms enable end-to-end research, clinical development, and manufacturing for pharmaceutical partners. Category: B2B biotech platforms serving pharmaceutical and biotech partners.

Paw Therapeutics applies AI to accelerate drug discovery and development in biotechnology. The company uses AI-driven Target Discovery Models and an Antibody Drug Library to identify candidates. It also offers an AI-powered Antibody Drug Optimisation Platform and a GMP-grade Pilot/Production Platform for antibody drugs. These platforms enable end-to-end research, clinical development, and manufacturing for pharmaceutical partners. Category: B2B biotech platforms serving pharmaceutical and biotech partners.